New Nano Approach Could Cut Dose of Leading HIV Treatment in Half
Latest results available at the University of Liverpool shows that nanotechnology can help in improving drug therapies performed for HIV patients. The said results have been presented at the Conference of Retroviruses and Opportunistic Infections (CROI) in Seattle.
This recent success in nanotechnology applies in HIV drug treatments has been the feature at one of the leading annual conference of HIV research at Seattle. This clinical practice and progress aided with the healthy voluntary trial were led by the Pharmacologist Professor Andrew Owen and Materials Chemist Professor Steve Rannard, Science Daily reveals. The experiment also collaborated with the St Stephen's AIDS Trust and the Chelsea & Westminster Hospital in London.
The experiment developed smaller pills that are better for patients and are also less expensive to produce. This discipline helped in changing medical science and has positively impacted clinically used therapies and diagnosis for HIV worldwide.
At present, HIV treatment requires daily oral dosing of HV drugs and has led to significant complications to many patients with varying conditions leading to non-adherence to therapies.
Nanomedicine is being further used as alternatives to improve drug absorption onto the body while reducing both the dose and the cost per dose allowing existing healthcare budgets to treat more patients.
CNBC further reveals that a new frontier is ahead of all people dealing with HIW. They are living longer and enjoying the long-term effects of medication. In the US alone, the economic toll of HIV is continuously increasing. It has already reached $27.5 billion and at present, there are already more than 1.2 million people in the US living with HIV.
Data also reveals that 700,000 people with AIDS have died since the beginning of the crisis. In 2014 alone, 12,333 deaths were due to HIV infection with 6,721 deaths attributed directly to HIV. Thus, further development of HIV drugs is being exploited.
This type of necrosis can arise from the use of anabolic steroids that can help people living with HIV to help them gain weight.